DE69705210T2 - Krampflösende, enantiomere aminosäure-derivate - Google Patents

Krampflösende, enantiomere aminosäure-derivate

Info

Publication number
DE69705210T2
DE69705210T2 DE69705210T DE69705210T DE69705210T2 DE 69705210 T2 DE69705210 T2 DE 69705210T2 DE 69705210 T DE69705210 T DE 69705210T DE 69705210 T DE69705210 T DE 69705210T DE 69705210 T2 DE69705210 T2 DE 69705210T2
Authority
DE
Germany
Prior art keywords
compound
mmol
liver
compounds
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69705210T
Other languages
German (de)
English (en)
Other versions
DE69705210D1 (de
Inventor
Harold Kohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69705210(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Publication of DE69705210D1 publication Critical patent/DE69705210D1/de
Application granted granted Critical
Publication of DE69705210T2 publication Critical patent/DE69705210T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69705210T 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate Expired - Lifetime DE69705210T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
PCT/US1997/004579 WO1997033861A1 (en) 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives

Publications (2)

Publication Number Publication Date
DE69705210D1 DE69705210D1 (de) 2001-07-19
DE69705210T2 true DE69705210T2 (de) 2001-09-20

Family

ID=21760388

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69705210T Expired - Lifetime DE69705210T2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate
DE122009000010C Active DE122009000010I2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate
DE69729392T Expired - Lifetime DE69729392T2 (de) 1996-03-15 1997-03-17 Krampfhemmende enantiomere Aminosäurederivate

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE122009000010C Active DE122009000010I2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate
DE69729392T Expired - Lifetime DE69729392T2 (de) 1996-03-15 1997-03-17 Krampfhemmende enantiomere Aminosäurederivate

Country Status (12)

Country Link
EP (2) EP1038522B1 (enExample)
JP (1) JP3145414B2 (enExample)
AT (2) ATE202079T1 (enExample)
AU (1) AU718577B2 (enExample)
CA (1) CA2248317C (enExample)
DE (3) DE69705210T2 (enExample)
DK (2) DK1038522T3 (enExample)
ES (2) ES2218024T3 (enExample)
FR (1) FR09C0006I2 (enExample)
NL (1) NL300376I1 (enExample)
PT (2) PT888289E (enExample)
WO (1) WO1997033861A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (en) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
EP1873527A1 (en) 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
US8093426B2 (en) * 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
CN102596897A (zh) 2009-08-06 2012-07-18 麦迪凯姆股份公司 一种n-(苯基甲基)丙酰胺衍生物的多种固体形态及制备方法
JP5564570B2 (ja) * 2009-09-25 2014-07-30 カディラ・ヘルスケア・リミテッド ラコサミドおよびその中間体の調製方法
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
US8759582B2 (en) 2010-02-08 2014-06-24 Natco Pharma Limited Process for the preparation of lacosamide
US8907132B2 (en) * 2010-02-09 2014-12-09 Msn Laboratories Private Limited Process for preparing (R)-2-acetamido-N-benzyl-3-methoxy-propionamide
EP2399901A1 (en) 2010-06-23 2011-12-28 Archimica GmbH Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
WO2012041986A1 (en) 2010-10-01 2012-04-05 Ucb Pharma Gmbh Process for the preparation of amino acid derivatives
WO2012051551A1 (en) * 2010-10-15 2012-04-19 Nektar Therapeutics N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
PL2444390T3 (pl) 2010-10-19 2017-06-30 Euticals Gmbh Sposób wytwarzania Lakozamidu
EP2645997B1 (en) 2010-12-02 2022-08-10 UCB Pharma GmbH Once daily formulation of lacosamide
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678469D1 (de) * 1985-02-15 1991-05-08 Res Corp Technologies Inc Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant

Also Published As

Publication number Publication date
PT888289E (pt) 2001-09-28
JP2000505476A (ja) 2000-05-09
DE69729392T2 (de) 2005-06-02
EP1038522A3 (en) 2003-01-15
EP0888289A1 (en) 1999-01-07
EP0888289B1 (en) 2001-06-13
ATE268169T1 (de) 2004-06-15
FR09C0006I2 (fr) 2009-12-18
DK0888289T3 (da) 2001-09-03
DE69705210D1 (de) 2001-07-19
ES2157567T3 (es) 2001-08-16
JP3145414B2 (ja) 2001-03-12
AU2539497A (en) 1997-10-01
CA2248317C (en) 2003-12-02
PT1038522E (pt) 2004-10-29
ATE202079T1 (de) 2001-06-15
CA2248317A1 (en) 1997-09-18
DE122009000010I2 (de) 2010-10-21
EP1038522A2 (en) 2000-09-27
EP1038522B1 (en) 2004-06-02
WO1997033861A1 (en) 1997-09-18
ES2218024T3 (es) 2004-11-16
NL300376I1 (nl) 2009-05-06
DK1038522T3 (da) 2004-10-11
DE122009000010I1 (de) 2009-05-20
FR09C0006I1 (enExample) 2009-04-17
DE69729392D1 (de) 2004-07-08
AU718577B2 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
DE69705210T2 (de) Krampflösende, enantiomere aminosäure-derivate
US5773475A (en) Anticonvulsant enantiomeric amino acid derivatives
DE602004008938T2 (de) Phosphorsäuresalz eines dipeptidylpeptidase-iv-inhibitors
DE69524246T2 (de) 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten
EP0270947B1 (de) Substituierte basische 2-Aminotetraline
DE69627852T2 (de) Verbindungen, die an einer neuen stelle auf rezeptor-stimulierten kalziumkanälen wirksam sind, verwendbar zur behandlung von neurologischen krankheiten
DD144761A5 (de) Verfahren zur herstellung von optisch aktiven phenethanolaminen
EP0400011A1 (de) Neue phenylethanolamine.
EP0916679A1 (de) Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2607592A1 (de) Acetylenderivate von aminosaeuren sowie verfahren zu deren herstellung
DE2846251C2 (enExample)
DE2006978C3 (de) N- [l-(3-Trifluonnetnyl-phenyl)-propyl-(2)] -glycinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3927049A1 (de) Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung
DE3872213T2 (de) 5-substituierte ornithin-derivate.
DE69734594T2 (de) Nmda (n-methyl-d-aspartate) antagonists
DE68905171T2 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
DE69827137T2 (de) Aminoethylphenoxyessigsäure-derivate und medikamente zur schmerzlinderung und förderung der entfernung von konkrementen bei urolithiasis
DE10048715A1 (de) Verwendung von Aminosäure zur Behandlung von Schmerz
DE3786865T2 (de) Aminosäurederivate enthaltende antikonvulsive Zusammensetzungen und Verwendung dieser Aminosäurederivate.
DE69413333T2 (de) Benzospiroalken-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2656088A1 (de) Neues benzylalkoholderivat und verfahren zu seiner herstellung
DE68910165T2 (de) Antihypertensive Sulfonanilide.
EP0491263A1 (de) Phenylalkylaminoalkyl-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69615845T2 (de) Polycyclische alkaloid-derivate als nmda-rezeptor-antagonisten
DD144764A5 (de) Verfahren zur herstellung von r-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylaminen